The industry claims China biological medicine industry follows and innovates for being mainly more practical

The industry claims China biological medicine industry follows and innovates for being mainly more practical
-Dialogue background
Our country is the fifth largest medical market in the world at present, it is estimated that will become the third largest medical market in the world by 2013. When the time comes, the medical market scale of our country will be increased from present 24,500 million dollars to 680- 780 hundred million dollars of 2013 years, second only to U.S.A. and Japan. Our country has more than 7000 of biological medicine enterprise in all, there is much total number, but technology is relatively backward, innovative and insufficient. How on earth does the biological medicine industry of our country develop? Holding a few days ago " The second capital innovative forum " Have, every expert proposes, " the source innovates " It is no doubt very important, but according to our country's present concrete national conditions, " follow and innovate " Seem to be geared to actual circumstances even more, even more important.
The biological medicine industry has already become the new point of economic increase
Host: By the look of above-mentioned data, the medical market of our country has kept increasing fast, as to biological medicine industry, how on earth is its future situation?
Zhang Li's sum: The biological medicine industry is a point of economic increase with enormous development potentiality, this industry is influenced by other factors relatively small. Because even there are enormous economic crises, people still want to fall ill to take medicine, so the influence received is relatively small.
Particularly, since global economic crisis of 2008, the impact on pharmacy enterprise is relatively small, the influence that the biological medicine industry of our country receives is smaller, even quite develop. That because our country research and develop cost to be relatively low, environment, too relatively loosely, especially country start " eleven 5 " from 2008 National great plan, special, has offered much support, very great opportunity for that the medical enterprises of our country developed, the growth of its output value and profit is very fast.
Hou YunDe: Developing the biological medicine industry should follow the international market situation. I think, the vaccine industry is that our country may turn to the industry of the most favorable development of the world market at present, it is a very important developing direction. Biotechnology has produced more than 200 types of new medicines and vaccine together, more than 400 types of vaccine have clinical experiments, its diagnosis reagent enters the family, increases fast. Vaccine controls infectious disease, present vaccine not only can be prevented and can also be treated, not only can prevent infectious disease, but also treat tumour. At present, U.S.A. FDA sanctions a tumour vaccine, estimates that can produce in a large amount 5 years later, this vaccine is effective and safer.
It becomes and develops the bottleneck that innovation is indifferent
Host: At present, what problems does industry's development of biological medicine of our country have?
Zhang Li's sum: The biological medicine industry is for the health quality of improving the people, treat disease. Such an industry is in the course innovating constantly forever. At present, H1N1 influenza that a lot of new diseases did not have treatment means such as SARS, break out not long ago, " super bacterium " appearing recently ,There is not a new disease of the medicine.
In addition, although a lot of diseases have medicines, with " develops " of disease ,The extant medicine can't already meet the new situation, such as tuberculosis being originally full of ideas and therapeutic, but the present tuberculosis fungus is able to bear nature, need new resisting the tuberculosis fungus medicine This has all brought the new subject to scientific research personnel, entrepreneur.
The biological medicine industry of our country has a lot of problems, but mainly autonomous innovation is indifferent, the industry disperses, the output value is lower, technologicaller the content is not high: The sum of the national medical output value is equivalent to the output value of an international big company; Industry's export quantum of biological medicine of our country is enormous, but in general, the added value is relatively low.

|